This is a non-revenue academic pilot with no disclosed financial terms. Monitor for future healthcare contracts or revenue-generating partnerships, but the filing provides no catalyst for near-term stock movement.
Price Chart
Executive Summary
Virtuix announced that Rutgers University has deployed its Omni One platform for research into AI-assisted neurodivergent therapy and behavioral analytics. This is a non-revenue academic collaboration that validates the platform's potential in healthcare but has no immediate financial impact.
Key Facts
- Rutgers University deployed Omni One at WINLAB for research on AI-assisted neurodivergent therapy and behavioral analytics.
- The collaboration focuses on autism therapy for children, evaluating attention, movement patterns, and response timing.
- No financial terms, revenue, or material obligations were disclosed.
- Virtuix's primary focus remains consumer entertainment and defense; healthcare is an exploratory vertical.
- The global ASD treatment market is projected to grow from ~$9.2B in 2026 to >$18B by 2034 (9% CAGR), per Fortune Business Insights.
Financial Impact
No revenue or financial commitment disclosed; immaterial to near-term financials.
Risk Factors
- Academic collaborations rarely convert to material revenue without multi-year validation cycles.
- No timeline or milestones for commercial healthcare product were provided.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3298589 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 6, 2026 20d ago | 8-K | $1.13 | awaiting T+20 | — | $0.6920 (+38.76%) |
Sep 30, 2026 26d ago | 8-K | $1.21 | awaiting T+20 | — | $0.6920 (−42.81%) |
Sep 23, 2026 4w ago | Press Release | $1.13 $0.7791 | ▼ −31.05% | ▼ −31.74% | $0.6920 (−38.76%) |
Aug 12, 2026 10w ago | Press Release | $1.70 | awaiting T+20 | — | $0.6920 (−59.29%) |
Aug 6, 2026 11w ago | DEFA14A | $1.69 $1.31 | ▼ −22.49% | ▼ −23.09% | $0.6920 (−59.05%) |
Aug 6, 2026 11w ago | 8-K | $1.69 $1.31 | ▲ +22.49% | ▲ +23.09% | $0.6920 (+59.05%) |
Aug 5, 2026 11w ago | Insider Cluster | $1.69 $1.31 | ▼ −22.49% | ▼ −23.09% | $0.6920 (−59.05%) |
Jul 31, 2026 12w ago | Insider Cluster | $1.56 $1.33 | ▲ +14.74% | ▲ +15.98% | $0.6920 (+55.64%) |
Jul 29, 2026 12w ago | 10-K/A | $1.61 $1.38 | ▼ −14.29% | ▼ −18.25% | $0.6920 (−57.02%) |
Jul 21, 2026 13w ago | 8-K / 424B5 | $2.29 $1.59 | ▲ +30.57% | ▲ +33.13% | $0.6920 (+69.78%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers